{"id":"W4386271084","doi":"10.1016/s2152-2650(23)01409-x","title":"MM-161 Talquetamab + Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated TRIMM-2 Results","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; Princess Margaret Cancer Centre","funders":"Universidad de Navarra; Janssen Research and Development; Memorial Sloan-Kettering Cancer Center","keywords":"Daratumumab; Multiple myeloma; Medicine; Oncology; Internal medicine; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003502337,0.0007979122,0.002780358,0.0007069386,0.0002715385,0.001811472,0.0009667897,0.0007740227,0.002945602],"category_scores_gemma":[0.0031135,0.0004270819,0.003271656,0.001104855,0.0003062942,0.001053151,0.00063527,0.001836698,0.0008038292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001510595,"about_ca_system_score_gemma":0.001379695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002346816,"about_ca_topic_score_gemma":0.007791628,"domain_scores_codex":[0.9987984,0.0004074539,0.0001739953,0.0001685727,0.0003020744,0.0001495204],"domain_scores_gemma":[0.9981712,0.0006553886,0.0005829189,0.00009549125,0.0002739036,0.0002209847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09914759,0.001555021,0.07063123,0.008710879,0.01937913,0.0002636545,0.0002002351,0.003284062,0.004655497,0.0008313144,0.03814226,0.7531991],"study_design_scores_gemma":[0.1057773,0.04434841,0.5166919,0.00711411,0.06942882,0.002429315,0.0004054432,0.004462321,0.00640809,0.002894578,0.2396662,0.0003735379],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.452192,0.4888093,0.001875187,0.009798301,0.002270889,0.001084732,0.01779948,0.0004346448,0.02573556],"genre_scores_gemma":[0.8121453,0.1273078,0.005928734,0.01186518,0.002148285,0.001232008,0.03429181,0.0001601871,0.004920754],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003502337,"threshold_uncertainty_score":0.01852238,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03261970465901573,"score_gpt":0.3211507475403363,"score_spread":0.2885310428813206,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}